Trial intelligence / Profile preview

Subanesthetic esketamine for enhanced recovery after laparoscopic bariatric surgery

ChiCTR2000040390Phase 4Not yet recruiting

Sponsor
First Affiliated Hospital of Jinan University
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of esketamine in obesity (4 arms), sponsored by First Affiliated Hospital of Jinan University. Primary endpoint: NRS pain score. Planned start Dec 2020; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

obesity

Beyond the preview

Go deeper on ChiCTR2000040390.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000040390.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call